Pioneering mRNA-Engineered Cell Therapy In and Beyond Oncology

Cartesian uses the RNA ArmorySM, its proprietary cell therapy platform, to engineer combination therapies into cells, and targets these cells precisely to the site of disease.

UNDERSTAND OUR SCIENCE

Our therapeutic candidates

Cartesian is conducting multiple clinical trials in respiratory, autoimmune, and oncologic disorders.

Explore our pipeline

Committed to delivering therapies to patients with unmet medical needs

Cartesian is an integrated team of scientists committed to delivering the safest, most effective mRNA cell therapies to patients with unmet medical needs.

Meet our team